As stated above, untreated depression poses clear risks to the expectant mother and the baby. Depressed mothers are less likely to attend recommended prenatal visits, more likely to engage in substance abuse, less likely to bond with their infants, and more likely to suffer postpartum depression -- all of which can affect the mother's ability to care for a baby before and after birth.
Most research to date has not shown serious long-term risks associated with use of TCA or SSRI antidepressants during pregnancy, although evidence is mixed. The most established risk seems to be that newborn infants can experience a transient withdrawal syndrome at birth with symptoms such as excessive crying, jitteriness, feeding difficulties, and irritability -- but the symptoms normally go away within two weeks.
Some reports have shown a higher risk of a condition called persistent pulmonary hypertension of the newborn (PPHN) in babies exposed to SSRIs in pregnancy. PPHN can be serious, but the overall risk of the condition is low even in exposed babies, so doctors may decide the benefits of continuing an effective drug might outweigh the risk. Some reports suggest an increased risk of congenital heart malformations with use of paroxetine (Paxil), but again, the overall risk remains low and moms who become pregnant while using Paxil may choose to continue the drug.
Most research does not reveal behavioral problems or other long-term side effects in children who were exposed to antidepressants in utero, although more research is needed. But research is equally lacking on long-term behavioral effects in children born to moms with untreated depression, and it is plausible that untreated depression could be equally or more harmful than exposure to antidepressant medications.
Although a 2010 study showed that SSRI use in pregnancy was associated with a 68% increase in risk of miscarriage, it can also be argued that the increase in risk might be outweighed by the benefits of using antidepressants. If the general population has a 15% risk of miscarriage, a 68% increase in risk would mean a 25% risk of miscarriage in women using the medications. Moms with a history of severe depression may decide together with their doctors that the risk remains acceptable. It must also be kept in mind that the association in the study remains correlational with no proof that the SSRI drugs were responsible for the added miscarriage risk.
On the flip side, many expectant moms may look at the safety data and decide that any added risk to their babies -- no matter how small -- is unacceptable. Although the symptoms of the neonatal behavior syndrome are transient, effects such as congenital heart malformations and PPHN can have long-term consequences. Some women may feel that if their babies developed these complications, they would never be able to accept that the complications might have been preventable.
Similarly, moms who miscarry while using an SSRI and then learn of the possible link between SSRIs and miscarriage may find the possibility of an added miscarriage risk equally unacceptable. Research suggests that moms with a past psychiatric history are at increased risk for suffering depression or post-traumatic stress disorder following a miscarriage, also, so an added risk of miscarriage in moms being treated with SSRIs should probably not be ignored.
Finally, questions remain over the benefit of antidepressants for milder to moderate forms of depression -- research has been mixed on the effectiveness of drugs over placebo for depression that isn't severe. Some women who are taking antidepressants might be able to manage their depression without medication, although those with severe depression may be less likely to cope without medical treatment.
Where It Stands
There are no easy answers. The right course of action probably varies by the individual. A mom whose depression has been milder and who has never been suicidal may decide with her doctor's advice to try going off her medications. But in contrast, for a mom with a history of suicide attempts who has not had improvement in psychotherapy and who is finally stable on an antidepressant medication, the risks of discontinuing the treatment might outweigh the risks of continuing the treatment.
As with most areas of healthcare, women need to discuss the benefits and risks of both courses of action with their doctors. Women who are already on antidepressants and who are concerned about the effects of the drugs during pregnancy should ideally talk to their doctors before conception, as a trial of discontinuing the meds might be best undertaken before pregnancy. Women who become pregnant while on antidepressants should not discontinue their medications without consulting their doctors -- even if the drug is to be stopped, it may be best to gradually decrease the dose rather than stopping cold turkey. Your doctor can also advise you on support groups or other non-drug therapies in your area that might help you manage your condition.
And finally, women who do decide to continue their medications during pregnancy should not feel guilty about doing so. Needing medical treatment for depression isn't a character flaw, and being a good mother also means taking adequate care of yourself so that you're able to function and take good care of your baby before and after birth. Even if a miscarriage or another pregnancy complication occurs while you're taking antidepressants, the link is by no means clear enough that you should assume the antidepressants were the cause -- it's equally or more likely that there was another explanation entirely. In the meantime, steer clear of judgmental types and don't feel that you have to defend your choices to anyone. Despite the many passionate opinions out there about this subject, you and your doctor are in the best position to know what's best for you.
Depression During Pregnancy. March of Dimes. Accessed: 8 Jun 2010. http://www.marchofdimes.com/pnhec/188_15663.asp
Fournier, Jay C; Robert J. DeRubeis; Steven D. Hollon; Sona Dimidjian; Jay D. Amsterdam; Richard C. Shelton; Jan Fawcett. "Antidepressant Drug Effects and Depression Severity." JAMA. 2010;303(1):47-53.
Misri, Shaila and Shari I Lusskin. "Depression in pregnant women." UpToDate. Accessed: 8 Jun 2010
Misri, Shaila and Shari I Lusskin. "Infants with antenatal exposure to serotonin reuptake inhibitors." UpToDate. Accessed: 8 Jun 2010
Misri, Shaila and Shari I Lusskin. "Management of depression in pregnant women." UpToDate. Accessed: 8 Jun 2010
Nakhai-Pour, Hamid Reza, Perrine Broy, Anick Bérard. "Use of antidepressants during pregnancy and the risk of spontaneous abortion." May 31, 2010 CMAJ.
Neugebauer, Richard et al. "Major Depressive Disorder in the 6 Months After Miscarriage." JAMA. 1997;277(5):383-388.
Pedersen, Lars Henning, Tine Brink Henriksen, Mogens Vestergaard, Jørn Olsen, Bodil Hammer Bech. "Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study." BMJ 2009;339:b3569.